Marta Miks

dsm-firmenich boosts HMO portfolio

dsm-firmenich has announced that it has received ‘no questions’ response letters from the US Food and Drug Administration (FDA) to its Generally Recognized as Safe (GRAS) notices submitted by Glycom A/S* for three new human milk oligosaccharide (HMO) ingredients.

Ingredients

DSM approves 3-FL ingredient for increased HMO access

Royal DSM, a global science-based company active in Health, Nutrition and Bioscience, have announced that its newly developed human milk oligosaccharide (HMO) – 3-fucosyllactose (3-FL) – has been approved as an ingredient in food applications in the US and Australia.

Dairy science, Regulatory

DSM’s HMO (2FL) gains regulatory approval for early life nutrition in Canada

HMOs are a component of human milk, and growing evidence shows that they have important immunity and gut health benefits, and a potential role in brain and cognitive development.

Dairy science, Ingredients